Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Travis D Alvine"'
Autor:
Ashley L Fink, Katherine L Williams, Eva Harris, Travis D Alvine, Thomas Henderson, James Schiltz, Matthew L Nilles, David S Bradley
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 11, Iss 7, p e0005721 (2017)
Dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS) are severe disease manifestations that can occur following sequential infection with different dengue virus serotypes (DENV1-4). At present, there are no licensed therapies to treat DENV-
Externí odkaz:
https://doaj.org/article/3def3c890e7c44748983404eef10f536
Autor:
Md. Obayed Raihan, Brenna M. Espelien, Brett A. McGregor, Courtney Hanson, Afrina Brishti, Nathan A. Velaris, Travis D. Alvine, David S. Bradley, Matthew Nilles, Mikhail Y. Golovko, Junguk Hur, James E. Porter
Publikováno v:
Vaccines; Volume 10; Issue 2; Pages: 321
BscF is a type III secretion system (T3SS) needle protein from Bordetella pertussis and has previously been shown to induce a sufficient Th1 and Th17 response in human monocytes and mice as a prerequisite for long-lasting protective immunity against
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3776e79fdea3310606d31555afbfdc0
Autor:
Md.Obayed Raihan, Brenna M. Espelien, Courtney Hanson, Brett A. McGregor, Nathan A. Velaris, Travis D. Alvine, Svetlana Al. Golovko, David S. Bradley, Matthew Nilles, Mikhail Y. Glovko, Junguk Hur, James E. Porter
Publikováno v:
Prostaglandins Leukot Essent Fatty Acids
Prostanoids are potent inflammatory mediators that play a regulatory role in the innate immune activation of the adaptive immune response to determine the duration of protection against infection. We aim to quantify the modulation of prostanoids prof
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1224799c6a1b1d1a5c46a088771114a3
https://pubmed.ncbi.nlm.nih.gov/35690004
https://pubmed.ncbi.nlm.nih.gov/35690004
Autor:
Jack Ballantyne, Travis D. Alvine, David S. Bradley, Riley Larson, Peter L. Knopick, Nathan Riha, Gerard Lina, Cédric Badiou, David S. Terman
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer
BackgroundAs the most powerful T cell agonists known, superantigens (SAgs) have enormous potential for cancer immunotherapy. Their development has languished due to high incidence (60%–80%) of seroreactive neutralizing antibodies in humans and tumo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e3b2d9f0161c52df513ac4afb3c293d
https://jitc.bmj.com/content/8/2/e001493.full
https://jitc.bmj.com/content/8/2/e001493.full
Publikováno v:
eLS. :1-9
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8a533c256e81aafd89f3fc214ccd855b
https://doi.org/10.1002/9780470015902.a0000945.pub2
https://doi.org/10.1002/9780470015902.a0000945.pub2
Autor:
Katherine L. Williams, David S. Bradley, Eva Harris, Ashley L. Fink, Thomas A. Henderson, Travis D. Alvine, James Schiltz, Matthew L. Nilles
Publikováno v:
PLoS Neglected Tropical Diseases
PLoS Neglected Tropical Diseases, Vol 11, Iss 7, p e0005721 (2017)
PLoS Neglected Tropical Diseases, Vol 11, Iss 7, p e0005721 (2017)
Dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS) are severe disease manifestations that can occur following sequential infection with different dengue virus serotypes (DENV1-4). At present, there are no licensed therapies to treat DENV-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32b3227e06adf4d21780a821723875bf
http://europepmc.org/articles/PMC5517069
http://europepmc.org/articles/PMC5517069
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 1531
Many Gram-negative pathogens utilize a type III secretion (T3S) system to directly deliver effector molecules into host eukaryotic cells to manipulate cellular processes. These surface-exposed syringe-like structures are highly conserved, necessary f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2f541e6e933a1776d7dc8d31bf6f27d7
https://pubmed.ncbi.nlm.nih.gov/27837493
https://pubmed.ncbi.nlm.nih.gov/27837493
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 1531
The type III (T3S) secretion system of many gram-negative bacteria is a surface-exposed protein secretion apparatus used to directly inject bacterial effector molecules into eukaryotic cells. These effector molecules contribute to bacterial pathogene
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::73ed9f5744a2844fd797e4da27c20a87
https://pubmed.ncbi.nlm.nih.gov/27837489
https://pubmed.ncbi.nlm.nih.gov/27837489
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 1531
The ability to express and purify recombinant needle proteins from the Type III Secretion System (T3SS) of many gram-negative bacteria has allowed us to develop novel experimental approaches, both in vitro and in vivo, to identify unique roles for T3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e62f6cd763e7a097375f12e51ccf0fb6
https://pubmed.ncbi.nlm.nih.gov/27837492
https://pubmed.ncbi.nlm.nih.gov/27837492
Publikováno v:
Methods in Molecular Biology ISBN: 9781493966479
The type III (T3S) secretion system of many gram-negative bacteria is a surface-exposed protein secretion apparatus used to directly inject bacterial effector molecules into eukaryotic cells. These effector molecules contribute to bacterial pathogene
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3d8c3df27953b3e5a3aabad2103b5e3b
https://doi.org/10.1007/978-1-4939-6649-3_13
https://doi.org/10.1007/978-1-4939-6649-3_13
